- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
BlinkRx Welcomes Former U.S. Senator Joe Manchin, Healthcare Executive Heather Manchin, as Senior Advisors
The digital health company adds bipartisan policy expertise and pharmaceutical industry leadership to support its mission of improving prescription drug access and affordability.
Feb. 5, 2026 at 5:15pm
Got story updates? Submit your updates here. ›
BlinkRx, a leading digital health company transforming access to prescription medications, has announced that former U.S. Senator Joe Manchin and healthcare executive Heather Manchin, former CEO of Mylan, have joined the company as Senior Advisors. The Manchins, through their strategic advisory firm Manchin Partners, will provide counsel to BlinkRx's leadership team as the company works to make the prescription drug system more transparent, competitive, and patient-first.
Why it matters
BlinkRx's mission to reduce costs, increase access, and simplify how patients receive needed medications aligns with the Manchins' decades of experience navigating complex healthcare policy challenges and confronting structural failures in the pharmaceutical industry. Their bipartisan approach and real-world expertise will be invaluable as BlinkRx continues to scale its innovative platform.
The details
As Senior Advisors, Senator Manchin will leverage his extensive background in public policy, while Heather Manchin will draw on her leadership experience as CEO of global pharmaceutical company Mylan. Together, they will provide strategic counsel to BlinkRx as it works to modernize the prescription drug ecosystem through data-driven technology solutions.
- BlinkRx announced the Manchins' appointments on February 5, 2026.
The players
Joe Manchin
Former U.S. Senator known for his bipartisan approach and focus on advancing solutions that deliver real-world benefits for American families.
Heather Manchin
Seasoned healthcare executive and former CEO of Mylan, one of the world's largest pharmaceutical companies, with a career focused on confronting structural failures in healthcare markets.
BlinkRx
A leading digital health company transforming access to prescription medications through its integrated data-driven technology platform.
Manchin Partners
The strategic advisory firm founded by Joe Manchin and Heather Manchin.
Matt Chaiken
Co-Founder and President of BlinkRx.
Geoff Chaiken
Co-Founder and CEO of BlinkRx.
What they’re saying
“I'm pleased to join BlinkRx and support work that brings people together around practical solutions to our healthcare challenges. No matter where you come from or what party you belong to, everyone agrees that patients deserve affordable medications and a system that works better. BlinkRx is focused on common-sense improvements that increase transparency, reduce unnecessary barriers, and help patients get the care they need, and I look forward to contributing to that effort.”
— Joe Manchin, Former U.S. Senator
“Much of my career has been spent confronting how opaque systems distort pricing and limit access for patients. BlinkRx represents the kind of private-market innovation healthcare has been missing and is the first market solution that is well-positioned to solve the access and affordability issue for patients and the industry.”
— Heather Manchin, Former CEO of Mylan
“After hearing Senator Manchin on the All-In Podcast and then meeting Heather, it was immediately clear that this was a team we wanted to work with. Senator Manchin's deep bipartisan policy experience and Heather's insight into how medicines are developed, distributed, and accessed will be incredibly valuable as we scale and continue building solutions that work for patients, providers, and pharmacies alike.”
— Matt Chaiken, Co-Founder and President of BlinkRx
“Senator Manchin understands how to take on hard problems and get results, especially in environments where progress requires trust, persistence, and practical thinking. We're honored to have him advising BlinkRx as we work to make the prescription drug system more transparent, competitive, and patient-first. Equally important, Heather Manchin brings firsthand experience leading a global pharmaceutical company and navigating the operational realities of healthcare.”
— Geoff Chaiken, Co-Founder and CEO of BlinkRx
The takeaway
The addition of the Manchins' bipartisan policy expertise and pharmaceutical industry leadership to the BlinkRx advisory team signals the company's commitment to driving meaningful change in the prescription drug ecosystem, with a focus on increasing transparency, reducing barriers, and prioritizing patient access and affordability.
